Wuhan LL Science and Technology Development Co., Ltd.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 17, 2027The maintenance fee for Complex disintegrant system for oral solid preparation and oral solid preparation comprising said complex disintegrant system (US 11,786,471) comes due Apr 17, 2027. Unpaid by Oct 18, 2027, it lapses early.
- 1 fee due Jun 30, 2027The maintenance fee for Posaconazole derivative, pharmaceutical composition and use thereof (US 10,517,867) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Oct 7, 2027The maintenance fee for Crystalline form of chemical compound, and preparation method, composition, and application thereof (US 10,611,757) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 19, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,708,306 | Benzimidazole derivatives and preparation process and pharmaceutical uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,517,867 | Posaconazole derivative, pharmaceutical composition and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,008,311 | Potassium salt of benzimidazole compound and preparation method therefor, composition and application thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,611,757 | Crystalline form of chemical compound, and preparation method, composition, and application thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,013,736 | Oral solid preparation and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,096,928 | Pharmaceutical composition In force · From the USPTO record | In force | From the USPTO record | |
| US 11,161,803 | Ammonium carboxylate compound, crystalline form, amorphous form and preparation method thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,786,471 | Complex disintegrant system for oral solid preparation and oral solid preparation comprising said complex disintegrant system In force · From the USPTO record | In force | From the USPTO record | |
| US 11,337,972 | Pharmaceutical preparation and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,503,444 | Compound Containing Benzene Ring and Application Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 16: 1 patent in force now held by others · 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 1 no status recorded